학술논문
Replacement of Adalimumab Originator to Adalimumab Biosimilar for a Non-Medical Reason in Patients with Inflammatory Bowel Disease: A Real-life Comparison of Adalimumab Biosimilars Currently Available in Italy
Document Type
Article
Author
Source
In: Journal of Gastrointestinal and Liver Diseases . (Journal of Gastrointestinal and Liver Diseases, December 2022, 31(4):411-416)
Subject
Language
English
ISSN
18418724